Baywood Wakes Up Export Business.Business Editors/Health and Medical Writers SCOTTSDALE, Ariz.--(BUSINESS WIRE)--April 25, 2000 Baywood International, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:BYWD) announced the launch of its patented anti-snoring product, Dr. Harris' Original Snore Formula, into Turkey with a population of over 55 million people. Baywood's distributor in Istanbul is an established marketer of pharmaceuticals and dietary products using sales representatives to sell directly to pharmacies This article is a list of major pharmacies (also known as chemists and drugstores) by country. Australia Pharmacies in Australia are mostly independently-owned by pharmacists, often operated as franchises of retail brands offered by the three major and doctors' offices. The distributor reaches over 18,000 pharmacies in Turkey alone. As part of the roll-out of the product, they are implementing a comprehensive advertising and marketing campaign which will encompass television, radio, trade magazines, direct-to-consumer mail and major newspapers. "Given the market potential of this product in the U.S. where approximately 40% of the population or over 100 million people are chronic regular snorers, its potential appeal internationally is so vast," stated Karl H. Rullich, Vice-President of International Sales for Baywood. "Since our distributor recognizes that potential, we are very pleased with their commitment in promotional support for the product and the size of their initial order of over two sku's for each of their 18,000 pharmacies," Rullich further stated. Dr. Harris' Original Snore Formula, introduced by Baywood in its SOLUTIONS(TM) line in July 1999, is a patented, all-natural product designed to relieve nighttime snoring snoring, rough, vibratory sounds made in breathing during sleep or coma. The noisy breathing is the result of an open mouth and a relaxation of the palate; it is frequently induced by lying on one's back. , one of the most common quality-of-life problems for adults. Medical authorities have estimated that up to 40% of the U.S. population, or over 100 million people, are chronic, regular snorers. Dr. Harris' Original Snore Formula is the only patented product in caplet cap·let n. A smooth, coated, oval-shaped medicine tablet intended to be tamper-resistant. form on the market that is composed of a combination of herbs and enzymes Enzymes Organic substances (proteins) composed of amino acids that trigger and regulate chemical reactions in the body. There are over 700 identified human enzymes. Mentioned in: Interactions, Nutritional Supplements and that is clinically tested to relieve snoring with 85% to 90% good to excellent results. Baywood is a consumer products company specializing in the development, marketing and distribution of natural-based products. The company's natural dietary supplement Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency diet - a prescribed selection of foods vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement lines are marketed under the brand names, PURECHOICE(TM) and SOLUTIONS(TM). The company's products are distributed through independent and chain health food stores, pharmacies, grocery stores, Vitamin World Vitamin World, one of the major brands owned by NBTY,[1] is a manufacturer of vitamins and nutritional supplements distributed in retail stores in the United States. Vitamin World has roughly 450 retail stores throughout the U.S. , GNC GNC General Nutrition Centers GNC Gas Natural Comprimido (Argentina) GNC Guidance, Navigation, and Control GNC Grand National Championship (ATV racing) GNC Global Navigation Chart , CVS/pharmacy and other direct-to-consumer channels both internationally and domestically. Contact Baywood International, Inc. at 1-888/350-0799 for more information or visit www.bywd.com. This press release may contain forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. , made in reliance upon Section 21D of the Exchange Act of 1934, which involve known and unknown risks, uncertainties or other factors that could cause actual results to differ materially from the results, performance, or expectations implied by these forward-looking statements. The Issuer's expectations among other things are dependent upon general economic conditions, continued demand for its products, the availability of raw materials, retention of its key management and operating personnel, as well as other uncontrollable or unknown factors. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion